Pharming Group N.V. - ADR

NASDAQ:PHAR

10.00

-0.01 (-0.10%)

4:47:08 PM EDT: $10.37 +0.37 (+3.70%)

Market Cap (Intraday)	684.46M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	1000

See more stats

Estimates Current Quarter

Revenue	$82.63 Million
Adjusted EPS	-$0.11

See more estimates

10-Day MA	$10.33
50-Day MA	$10.40
200-Day MA	$9.07

See more pivots

Pharming Group N.V. - ADR Stock, NASDAQ:PHAR

Vondellaan 47, Leiden, Zuid-Holland 2332 AA

Netherlands

Phone: +31.71.524.74.00

Number of Employees:

http://www.pharming.com

Description

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONESTÃ?Â®, JoenjaÃ?Â®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.